Episode 19: Your Pharmacy, Your Voice: Why HR 3164 (ECAPS) Needs You

In this episode of Independent Insights, host Suzanne Feeney sits down with Josh Babb, Senior Director of Government Relations at McKesson, to unpack H.R. 3164, the Ensuring Community Access to Pharmacist Services Act (ECAPS). This bipartisan bill could be a game-changer for independent pharmacies, finally allowing Medicare Part B reimbursement for pharmacist-provided services in states where they’re already authorized to deliver care. 

If you’re an independent pharmacist, this episode is a must-listen. You’ll hear real stories, understand the legislative landscape, and walk away with clear calls to action, from contacting your legislators to preparing your pharmacy for expanded services. ECAPS isn’t just about policy, it’s about people, access, and the future of pharmacy.

Host
Suzanne Feeney, PharmD
Sr. Director, Pharmacy Solutions
McKesson / Health Mart

Guests
Josh Babb
Senior Director, Government Relations
McKesson

Resources
Health Mart University (HMU) for: 

• Helpful CE courses and more on advocacy
• Health Mart pharmacists to claim their CE credit for weekly GameChangers episodes

Action Items for Listeners:

1. Know Your Legislators
   Check if your representatives are co-sponsors of H.R. 3164:
   Find Your Representative & Bill Status
2. Contact Your Legislators
   Call or email your representative.
   Share personal stories of patient impact and care gaps.
   Ask for their support or thank them if they're already co-sponsors.
3. Subscribe to Advocacy Updates
   Stay informed and get involved through Health Mart's advocacy portal:
   Health Mart Advocacy Portal 
4. Prepare Your Pharmacy
   Start offering eligible services (flue, strep, RSV, COVID-19).
   Explore billing options (commercial insurance, cash).
   Get operationally ready for Medicare reimbursement.
5. Host a Legislator Visit
   Interested in hosting a member of Congress in your pharmacy?
   Listen to Episode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy.
   Reach out to McKesson or Health Mart to get connected.

The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Transcript

Suzanne: [00:00:00] Welcome to Independent Insights, the McKesson Health Mart podcast, dedicated to the heart of community care- independent pharmacy. I'm Suzanne Feeney, pharmacist and senior Director of Pharmacy Solutions at McKesson Health Mart. Today we're going to dive into a game changing piece of legislation, HR 31 64, which is ensuring community access to Pharmacists Services Act, or as we all know, ECAPS. At its core, this bill addresses a critical gap. Pharmacists in many states are already authorized to provide essential healthcare services, but Medicare is not paying for them. That means seniors, especially in underserved areas, are missing out on care they desperately need from providers they trust.

Are you looking for ideas to grow independent pharmacy and make a greater impact in your community? Look no further. Welcome to Independent Insights, the podcast brought to you by Health Mart. Episodes delve into a wide range of topics to provide you with the practical strategies, expert insights, and [00:01:00] inspiring stories to help you and your pharmacy excel.

The information provided is intended for informational purposes only and does not constitute clinical, legal, or any other type of professional advice from Health Mart, McKesson, or its affiliates and subsidiaries (“McKesson”). You acknowledge and agree that McKesson will have no liability with respect to, or relating to any information presented in this podcast. Pharmacies are encouraged to consult with their legal and business advisors before making any decisions that could affect their business operations. 

Pharmacists are expected to exercise reasonable care as dictated by legal and professional standards and are ultimately responsible for decisions related to patient care and medication management. It is your responsibility to review and comply with all applicable state and federal laws, rules, and regulations governing your business operations. This includes laws applicable to [00:02:00] businesses in general, those pertinent to employers, and those specifically regulating the practice of pharmacy.​

Suzanne: So let me just share a quick story.

A few months ago I was speaking with a pharmacist in a rural, underserved area of the US who had been helping a long-term patient and community member. The pharmacist had built a trusting relationship with both the patient and the patient's prescriber over many years. As a result of the pharmacist interventions, they helped the patient avoid a costly ER visit, but because Medicare doesn't recognize pharmacists as providers, none of that care was reimbursed. Classic story for all of you listeners. I know, but that pharmacist told me I didn't do it for the money, but I can't keep doing it for free. I think that really sums up with where we're at right now in the profession and the reality that ECAPS is trying to change as a first step.

So if you're an independent pharmacist, this is your moment. ECAPS could redefine your role, expand your impact, and unlock new opportunities to serve your community. Joining me on this [00:03:00] episode is Josh Babb, Senior Director of Government Relations at McKesson, and he's here to help us unpack what this bill means, why it matters, and how you as pharmacy owners, pharmacy technicians, and pharmacists can be part of the movement to make it law. Josh, I have to say this really feels like a defining moment for healthcare access across the U.S. and I'm just curious, let me get into the real question here. Why do you think this year could be different? 

Josh: First of all, thank you so much for having me. And we do hope that this year is different. I think there's a history with this piece of legislation and it's had its moments across the last couple of years, and it's been tough because I don't think that the reason we don't currently have a piece of legislation passed in a law has anything to do with the legislation itself.

Rather, it's been to do with the environment surrounding it, and what I think that we're seeing this year that could prove, fertile for this piece of legislation in particular is that we have members of Congress in particularly [00:04:00] influential positions who are very familiar with rural America and the challenge of access to care in those areas.

And in particular, chairman of the House Ways and Means Committee, Jason Smith represents a very rural area. In his neck of the woods in Missouri, as well as Adrian Smith who was actually sponsoring this piece of legislation represents a very rural area in his home state of Nebraska.

And so the combination of these two members who have particular understanding of those challenges as well as a desire to help provide access where it matters most for the patient gives us a unique opportunity to move a piece of legislation like this that, quite frankly, otherwise could fly under the radar as they're discussing larger packages or committee activity, or trying to ultimately move the needle on some, thorny issues in terms of what's happening on Capitol Hill right now. So I think all the right pieces are here. Whether it be lining us up for, committee activity and consideration or regular order, or some sort of larger [00:05:00] healthcare package that comes together all the right opportunity exists. It's just about a matter of helping it cross the finish line at this point.

Suzanne: It's a matter of timing. I know in past years there's been different barriers that have popped up. And I know that you've participated in supporting this work and this bill for the past three years, so can you talk to us a little bit about maybe what has changed with how the bill is being positioned to overcome roadblocks and I guess to make that a little more specific, I remember in past years participating in the advocacy fly in and having some conversations with my representatives in the state of Illinois. And one of the key questions that came up as a barrier was expanded scope. And we know that this doesn't expand scope, what this does is allows pharmacists to practice within the scope that's already set in their state law. So is that still a barrier? Are there different specific barriers? Help our audience understand what stories they can share with their legislators to help advocate and push this forward.

Josh: That's a great question. I think, primary barriers right now [00:06:00] are creating a sense of urgency in Congress. Because I do think that the further that we get away. From the COVID-19 pandemic, which you know. Was really a tangible association of the services that pharmacists do and can provide in their communities in a very unique setting.

And the further we get away from that the further we get away from members of Congress who saw pharmacists, really performing up to the full scope of both what they're licensed to do, as well as they're fully capable to do is in, in terms of like healthcare providers in their community.

And the further we get away from that, the more challenging it's to tie some of these like very tangible, natural stories together. And I would say that, the thing that we're trying to do both at McKesson as well as through our participation in the Future Pharmacy Care Coalition, and the thing that I would urge anybody that's listening to this to do is to continue to provide a sense of urgency in their conversations, either with, district staff and some of these congressional [00:07:00] offices, or if they have the time to call their congressman to write a letter to participate in some of these advocacy campaigns that, that obviously Health Mart and our Health Mart advocacy sites are putting on to encourage their members of Congress to not let up either to co-sponsor the bill if they haven't already or if they have co-sponsored the bill, raise it with their committee leaders to say, the bill deserves an opportunity for full committee hearing as well as the bill deserves an opportunity to be put in a meaningful piece of healthcare legislation that passes. And it's that urgency that really is only created when constituents, take the time to reach out over and over again because it's that drumbeat of activity and resounding advocacy if you will, that really generates a buzz. For instance, McKesson has done a fly in through our advocacy ambassadors program back in the summer that generated a whole host of new co-sponsorship as well as interest in buzz, if you will, around it, which is great. But it's a flash in the pan opportunity and trying to find ways to continue that advocacy, I think is very important. [00:08:00] And then the other thing I would say is in addition to, creating a sense of urgency is, utilizing their own personal stories. Because I really do believe the success of this legislation is less based on the technical merits of the legislative text. And it's more on members of Congress understanding, what pharmacists in their congressional districts go through on a day in and day out basis. McKesson, if there are, many ways that, we try to connect congressional offices to the pharmacy community is hosting members of Congress, inside Health Mart Pharmacies. Yeah. In their districts, whenever possible. And we continue to ask for folks you're interested in hosting a member of Congress in your pharmacy, raise your hand.

Say something, we're happy to make, connect the dots where we can and help facilitate that, which I think is very meaningful context for members of Congress. But it's that connection that doesn't naturally exist a lot of times between the [00:09:00] pharmacy community and Congress and so it's personal stories, it's the challenges that pharmacists face on a day in and day out basis in terms of meeting the needs of patients, but also keeping the lights on in their pharmacies as well as the whole host of reimbursement challenges that they're facing. And I think we very much understand that this ECAPS legislation is not an end all, be all piece of legislation for pharmacists.

It's one step that plugs the gap or a hole in the larger reimbursement problem for pharmacists. But I think it's direct personal advocacy, on McKesson's behalf, but also on the behalf of independent pharmacy owners of how this legislation at least is, one brick in the wall of beginning to solve the problem and ensuring the independent pharmacy is alive and well in these rural communities for a long time to come.

Suzanne: Yeah. So many tangibles and so many thoughts there. And you answered my question are personal stories just as impactful as data? And it sounds [00:10:00] like the answer is a resounding yes. Share those personal stories of the patients that are being supported through our community pharmacies but also the day-to-day challenges that come up in the pharmacies and really painting that picture. I'm gonna give some clear call to actions for those listening 'cause I always appreciate those and we will put these in the show notes and we'll put some links in there to make it really easy for all of you. But for the state you're in, do you know if your representatives are co-sponsors? So we can put the link in there where you can easily access that and check it. And if they are co-sponsors, thank them for that, and it gives you the opportunity to reach out and share some of your stories. And if they're not Josh, is it okay to ask for that commitment? How do you recommend pharmacists go about that? Because it's one thing to say, hey, I support this and share this. But if you come in with that approach of asking for commitment or what do I need to do to move you to change, is that a good approach when having these conversations? 

Josh: Yeah, I think it's, I think it's the right approach, and I think that there's no better messenger than the pharmacist themself.

I think McKesson and our federal engagement opportunities [00:11:00] here in terms of how McKesson engages with members of Congress, their staff. I think it's robust, it's healthy. We've got great relationships. They respond well to those conversations, but they will never respond as well to our conversations as they will to having a conversation with a constituent and with somebody who's closest to the issue. And so there's no better advocate for patient care and the challenges in the pharmacy community than the pharmacist. And so I would highly encourage them to ask, in a pointed way for support on the legislation. And if they already support it, then for their voice in advocating with congressional leadership to make room for this legislation as Congress considers, what they're gonna do this fall. 

Suzanne: Yeah. And I wouldn't be surprised too to our listeners out there that this could be the start of a relationship and because I know that when I got engaged with this work, you build on the relationships. There's staffers that are back year after year that you talk to as they're in session and they build upon that. And that's how we've been able to facilitate some visits within Health Marts, and [00:12:00] oftentimes then those staffers or even that legislator will connect back to the pharmacy when, hey, I'm reading about this, what does this look like in real life? And that was something that was also really eye-opening to me when I got to visit with legislators and be in their offices. They're real people answering the phones that are logging the calls, and they take it really seriously. So that to me, sitting there as I was waiting for my visits, I was like, oh, these calls that I'm making now I see the other side of it, and that does create a true impact. So I think that's nice to know. 

Josh: Yeah. It's such a good point. You have to humanize these interactions. I think it's, very important to understand that yes, members of Congress, despite, what is on TV are real humans with families that live in these congressional districts and they face the same challenges that many of us do just in a different capacity. And I think the message from pharmacists to these members of Congress should be, and it should be no surprise to anybody listening to this right now, as pharmacists you were highly trained and trusted yet still underutilized in a [00:13:00] broader healthcare system. And during COVID-19, pharmacists stepped up in a big way. They delivered care and vaccines and reassurance when it was needed most, but some of that is gone by the wayside in the years past. And part of the advocacy message that we're pushing across and as part of our advocacy strategy on your behalf is that we recognize the valuable role that pharmacists play and we're working to ensure policy makers do as well. So I would encourage any pharmacists listening to this to be willing to step into that same space themselves and advocate for them on the valuable role that you play in the healthcare system.

You're listening to Independent Insights, a McKesson Health Mart podcast with host Suzanne Feeney, Senior Director Pharmacy Solutions at McKesson Health Mart. And guest, Josh Babb, Senior Director of Government Relations at McKesson.

Let's continue. 

Suzanne: One more question that I get quite often for people who are maybe hesitant to reach out or one of their [00:14:00] concerns is that because this bill is up for a vote a third time has it been diluted or is there still an appetite to listen, because I have a lot of pharmacists that will say to me like, oh gosh, this is year three. And we talked about some of the reasons why and the challenges and what we can do, but do you feel like that the sense of urgency is maybe diluted a little bit and so the pharmacist can help to revive that urgency in painting those pictures and is there any sort of hesitation to engage in conversation around this?

Josh: I don't think there's a hesitancy at all. And, I would say, to dispel the myth of, has it been around too long, we're on iteration three, is that a bad thing? I would say, look, some of the most well thought out and influential piece of legislation that this country has passed into law across the last a hundred years are pieces of legislation that took a couple tries. It took several cracks to get it right. And I think we can equate the conversations that we're having right now around the value [00:15:00] of elevating the practice of pharmacy to that same scope. I will tell you the most meaningful conversations and the most poignant way that McKesson can make this point, is that we are working to make the capabilities that every pharmacist has and the role that they've played, several years ago now in helping fill very important gaps during the pandemic, permanent so that their ability to serve patients doesn't depend on a public health emergency. I think that is, part of the message that we're weaving in here. Yes, we're on iteration three of the bill. Have some of the words changed, have some of the paragraphs moved around? Sure, but at the heart of the piece of legislation is to take, part of this national success story, if you will, and place permanence around it so that independent pharmacy and pharmacists at large are part of the solution going forward so that, their ability to serve patients doesn't depend on a public health emergency and doesn't depend on caveat or a carve out, or special tranche of funds, but rather, through Medicare Part B [00:16:00] reimbursement for these very select set of services that pharmacists can be reimbursed for the services that they provide. And I think that message carries water depending on, regardless of whether or not it's iteration one or iteration three. Again, a lot of this has to do more with timing and political environment than it does the merits of the legislation. 

Suzanne: That's really helpful. And as you were talking, I couldn't help but think about where I live, there's been a lot of conversation about one of our for-profit hospitals closing. And in talking with some community members I raised my hand and I said, Hey, as we're planning for how to best support these patients, most of whom are actually using that healthcare system from an ER perspective as a primary care physician. Do you realize what pharmacies can do as far as test and treat, as far as immunizations? And as I'm sitting in a room with a lot of other healthcare providers they weren't aware of that. And when I mentioned ECAPS and what we were doing, they're like, oh yeah, that's right. And then it became, let's talk more. Let's engage more. I think using what you're seeing in the news in your local community to share those stories of the impact you can make as it relates to current day problems helps to heighten that sense of urgency. [00:17:00] I know that as I would call, my legislators around this, that would be a talking point, hey, we're faced against this challenge. If ECAPS is able to be passed, here's what it can solve and help with those displaced patients. So I think there's a lot of different things that we can use from what's happening to elevate that sense of urgency. And I think that brings up a key point and just, maybe if you don't mind, Josh, backing into this a little bit, but I think most people are aware of what's in ECAPS, can you give us that high level overview and what those services and vaccines are that are being called to be covered?

Josh: Sure. That's a great point. As you've introduced it already ECAPS is the ensuring community access to Pharmacy Services Act. It's a bipartisan piece of legislation, which is a direct response to what we learned during the pandemic that pharmacists or essential providers of care. And so this specific piece of legislation would allow Medicare to reimburse pharmacists for services like flu, RSV, strep and COVID-19 testing and treatment services many of you are already providing today. But most importantly, this bill [00:18:00] respects state scope of practice laws, so it only applies in states where pharmacists are already authorized to deliver these services. And, our advocacy strategy behind it should, surprise no one here. We're actively advocating for the legislation because we know how critical these services are to your patients and to your business. This legislation in its simplest form, is about leveling the playing field so that pharmacists can compete and care without barriers being placed around them. It's, being championed again. Adrian Smith and Brad Schneider, both of them very close to the pharmacy community, both of them sitting on the House Ways and Means committee. It's also championed by some of the members of Congress that are also close to the pharmacy community. Pharmacists themselves representative Buddy Carter, as well as Diana Harshbarger. Two members on the Republican side who are pharmacists who have decades of care in their own pharmacy settings for patients. And so they understand the value of at least getting our toe in the water in terms of Medicare Part B reimbursement. [00:19:00] And I would just say, it's not just a policy idea. I think this is a well vetted piece of legislation that's moving forward because of the groundwork that McKesson has laid, but really the groundwork that pharmacists have laid for it.

And so at the end of the day. Our goal is to continue to meet with lawmakers, educate staff, and build coalitions so that it's not just a concept, rather it's like a momentum that we hope ultimately drags this piece along. 

Suzanne: Yeah, for sure. You mentioned this is a toe in the water and I wanna expand on that just a little bit.

So as we kind of look out at the profession and the changes that could happen this year and then five years or 10 years, and just really the evolving landscape of how care in this digital environment where things are so convenient and so different than maybe they were 40 years ago, or even really 15 or 10 years ago.

So if you can just maybe a little bit talk about what long-term changes you could foresee in the overall healthcare landscape if pharmacists are recognized with this first step as providers under [00:20:00] Medicare Part B for those very specific services that you mentioned.

Josh: I think it's important to note, and I've called this out before, this is not an all encompassing piece of legislation. This is, really the entry point, if you will, for pharmacists into this world of medicare reimbursement. And so obviously the tailored set of services for Medicare reimbursement here. But I really think it's, it's the proving ground for pharmacists. These are services that pharmacists have been performing in large part for a lot of years, but certainly in the last five years or so, where their communities have really rejiggered the way that they've consumed healthcare in those districts and in those communities. For things like testing, treatment, vaccination services. And so pharmacists have performed them, previously they performed them under some temporary authorizations where there was temporary federal dollars attached to them. And a lot of that is dried up, but the pharmacists have continue to perform the services. And so the hard part has been done.

And so, you know what I would say to anybody who looks at this piece of legislation and says, okay if this piece of legislation passes, like how does my [00:21:00] life change tomorrow? If you're a pharmacist, like your life changes A, because Medicare reimbursement is a new concept and albeit in limited form here, this is a new opportunity for pharmacists to perform services and be paid for them through the Medicare system, but it's also a chance to lean in. I think it's a chance for pharmacists to really fully lean in, utilize the services that they can be reimbursed for, and again, in an official capacity. Prove the worth of pharmacists and their ability to care patients in this unique setting, in this unique way.

Because I think at the end of the day, there's been a lot of give and take and start and stop in the pharmacy community, and I think there is hesitancy of which I think all of us should recognize to fully lean in when you don't know whether or not the reimbursement will follow. And so if this legislation passes, we know the reimbursement will follow.

And so pharmacists really should take that opportunity to fully adapt their practices to lean in on these sets of services and be reimbursed for them accordingly. Such that as opportunities [00:22:00] come down the road for future reimbursement models to be adjusted pharmacists will be well positioned for 'em.

Suzanne: Yeah. Well, I'm sitting here thinking if I were still practicing in a pharmacy or own my own pharmacy, I would certainly be doing all of these already, whether I can bill commercial insurance or bill different things is one thing. And so if it's me, and I know this is coming, we're in year three there's a lot of reason to have faith in this. It doesn't hurt me to get started with this. So I think that's a step that's gonna get you ready and set up from an operations perspective in the pharmacy. So you know how to do this and then if the reimbursement comes great it's another opportunity for you to bill for that.

So I think there's definitely different approaches to this and I really like that you call out, like this is the first step and then lean in and look and there could be a lot more.

Josh, it's been really great talking with you today. Before we wrap up and go, I know you called attention that there's bipartisan support for this bill and that's still resonating and I think that's really important. I think this bill really connects to larger healthcare challenges that we're [00:23:00] seeing out there, and there is a way for our listeners to really have a call to action and create that sense of urgency with their legislators. Anything else that our independent pharmacies should be thinking of as far as an advocacy or preparation that could really help pass this forward?

Josh: Yeah. First of all, this is, a lot of information to take in. Especially if this is your first time hearing about this legislation, McKesson's involvement in it. I mentioned the Future Pharmacy Care Coalition. It's just a lot. There's a lot to digest here.

However, I would offer up to you if you're a McKesson Health Mart customer and you're listening to this, it's one of the reasons why I'm here. It's exactly why McKesson is doing this important work so that you guys don't have to navigate federal policy alone because federal policy is challenging you're doing the hard work, you're taking care of patients, allow us to do a lot of this navigation.

And I would offer up if you've got questions about how this legislation impacts your pharmacy or how you can get involved I'm here to help. The McKesson team is here to help. If you're part of Health Mart, you're already part of the solution. We're [00:24:00] advocating for you guys every day. And we want to help you, plug in where possible. I know that we have a public policy page where you can see what McKesson is doing to support independent pharmacy. And if you're not already plugged into our advocacy updates through Health Mart, the way to do that you can go to the advocacy portal at myhealthmart.com and sign up. You can get news updates. You can see how you can, be more involved and how you can advocate on a more personal level. That, advocacy is really number one. We can't do it without you. This legislation has a good chance and we're here to advocate for it on a day to day basis, but it's really a partnership.

And so we need every pharmacist to get involved. 

Suzanne: Yes we do. And give us the timeline, right? So you live in the world where, you know when's in session and when the votes are. But for those of us who are like, oh my gosh, how is it this time of year already? What's the timeline for this?

Josh: It's a good question. For those of you that that don't necessarily track the congressional sessions so they do line up in two year cycles. So we enter, we entered a new Congress in January of this year. That Congress lasts for two years. So the piece of legislation that we're currently talking about right now is [00:25:00] introduced this year and has a shelf life that exists through December 31st, 2026. 

Suzanne: So you've been hanging out with pharmacists shelf life. I've got that. Good job. Well done. 

Josh: So we are currently working to pass this piece of legislation before that shelf life expires. And so we think there's, there's a great environment that will exist later this fall for both possible committee consideration, which is a critical step in moving a piece of legislation in Congress as well as the must pass piece of legislation that this bill could get married up to and ride along with if some of those opportunities fizzle, we still do have calendar year 2026 where some of those opportunities will again, continue to reemerge and provide opportunities to move things along. So it's tough to say in terms of specific timing, but I will tell you, between now and fall of 2026 is really our best opportunity to advocate, make these messages known and find the right opportunity for this legislation.

Suzanne: Awesome. All right, so we have plenty of time to get this job done. Recapping some calls to action. We're gonna put some links in the show notes for all of [00:26:00] this, but definitely knowing your legislators, if they're co-sponsors or if they're not. And so that helps you to just thank them or give them a call to action.

Call, email, reach out, share your stories, use those advocacy updates that are available. We'll put links to show notes on that so you can subscribe and stay abreast of what's happening. Josh, maybe we'll have you back in, a couple of months to give an update and see if anything has changed and check in.

And I would also just say as a pharmacist and to pharmacists, get ready. Start thinking about if you're not doing these services or not offering these vaccines, how do you get that implemented in your pharmacy? Reach out to peers, reach out to resources so you can get comfortable and be ready for when this happens.

Josh, thanks so much for your time today. This act, I think for the first time would be so exciting to see that Medicare part B coverage for pharmacist services in any area where state law permits it would be able to provide care and get billed for that. We're really glad to have you here today. Thanks so much for your time.

And to our listeners, ECAPS act it's not just about policy, it's truly about people. It's [00:27:00] about the communities and the patients that you serve. It's about ensuring that seniors and underserved communities have access to care that they need from you all, which are providers that they trust.

Independent pharmacies has always stepped up during the pandemic, during flu season every year, and every day in between. And now it's really time for policy to catch up, so I'm excited about this, and if you believe in the power of pharmacy to transform care, now is the time to act. So if you've listened to this and you've been with us for this last 30 minutes definitely put something into action and contact your legislators, share your stories, and really join the movement to pass HR 3164 to secure provider status for pharmacists under Medicare Part B.

Because when pharmacists are empowered, communities thrive.

Subscribe to Independent Insights wherever you listen to podcasts New episodes are released weekly Together let's make a lasting impact and shape the future of pharmacy